(Date:5/20/2013)... (PRWEB) May 21, 2013 Grace ... specializing in “game-changing” life science and health related private ... Dergham to its International Project Team. Dergham's expertise in ... greater multi-cultural depth to Grace Century as it continues ... globe. , Ms. Dergham holds both an under graduate ...
(Date:5/20/2013)... May 20, 2013 (PSHR) Pacific Shore Holdings, ... products across a broad range of product categories ... investor relations firm, BlueWater Advisory Group, to provide ... trading process, and to direct the company,s outreach ... Matthew Mills , Pacific ...
(Date:5/20/2013)... ROCKVILLE , Md. and BALTIMORE ... Inc. (BHI), a regional private-public partnership focusing ... to early-stage funding in Central Maryland ... Aiyar, Ph.D., M.B.A., as the first Entrepreneur-in-Residence (EIR) ... (NIH) National Heart, Lung and Blood Institute ...
(Date:5/20/2013)... Interventional cardiologist Tony Farah, MD, and his colleagues ... Institute have helped pioneer many breakthroughs in the ... the past three decades, from new disease-fighting medications to ... stent implantation. , Today, AGH officials announced that the ... the study of a novel, first-of-its kind investigational device ...
Breaking Biology Technology:Dalia Dergham Joins Grace Century FZ LLC International Project Team 2Pacific Shore Holdings Retains Investor Relations Firm 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 2BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 3BioHealth Innovation, Inc. Names Ram Aiyar as Entrepreneur-in-Residence to NIH National Heart, Lung and Blood Institute 4Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 2Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 3Allegheny General Hospital Cardiovascular Institute Becomes Exclusive Pittsburgh Site for Study of Novel Coronary Artery Disease Device 4